Learning Objectives:

At the end of this module the learner will be able to:

• List the evidence-based clinical practice recommendations on prevention, diagnosis and management of T2D at primary care level
• Discuss the recommendations on lifestyle and pharmacological management of T2D
• Understand the management of T2D with complications, in special population, at-risk individuals and their referral

Learning Objectives

At the end of this module the learner will be able to:

• Describe the pharmacology of glucose-lowering medications in diabetes
• Describe the application of various glucose-lowering medications such as metformin, sulfonylureas, alpha-glucosidase inhibitors and thiazolidinediones in clinical practice
• Discuss the guidelines-based approach in choosing glucose-lowering medications in the management of diabetes

Learning Objectives

At the end of this module the learner will be able to:

• Discuss the pharmacology of oral glucose-lowering medications in diabetes
• Describe the clinical application of various oral glucose-lowering medications including gliptins (dipeptidyl peptidase-4 inhibitor), glucagon-like peptide-1 (GLP-1) receptor agonist, sodium-glucose cotransporter-2 (SGLT-2) inhibitors in clinical practice
• Discuss guidelines-based approach in choosing oral glucose-lowering medications in the management of diabetes

• Webinar date and time : 09th Oct, 14:00 CET
• Register Now : https://s2.webeventconsole.com/IDF/IDFSchool-webinar1/t2d-cardiorenal/registration

Learning Objectives

At the end of this module the learner will be able to:

• Discuss the overview of diabetes and cardiovascular diseasetes
• Review the different types of cardiovascular complications
• Describe the pathophysiology of cardiovascular complications in diabetes
• Discuss the epidemiology of coronary heart disease, cerebrovascular disease and peripheral artery disease
• List the potential risk factors associated with cardiovascular complications
• Identify the screening and diagnostic tests for detecting cardiovascular complications in people with diabetes
• Discuss the management strategies for cardiovascular complications

Learning Objectives

At the end of this module the learner will be able to:

• Provide a brief overview of diabetic kidney disease
• Discuss the global prevalence of diabetic kidney disease
• Identify the potential risk factors associated with the development of diabetic kidney disease
• Describe the pathophysiology of diabetic kidney disease.
• Review the screening and diagnostic tests for detecting diabetic kidney disease
• Discuss the guideline recommendations in the management of diabetic kidney disease

• Webinar date and time: 20th Nov, 13:00 CET
• Register Now: https://s2.webeventconsole.com/IDF/t2dcardiorenal2/vregistration.aspx